Gene, Cell Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT06462729
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
Phase: Phase 1/2
Role: Lead Sponsor
Start: Nov 12, 2024
Completion: Dec 31, 2027
Loading map...